Possible mesalamine-induced pericarditis: case report and literature review

Pharmacotherapy
Robert A Waite, Jennifer M Malinowski

Abstract

Pericarditis should be considered in any patient complaining of chest pain and/or dyspnea who is taking a product that contains mesalamine or sulfasalazine. A 41-year-old woman was taking mesalamine 800 mg 3 times/day for 3 weeks before hospital admission. She complained of sharp, pleuritic chest pain that radiated down both arms and increased in intensity when lying down. She was diagnosed with pericarditis based on clinical presentation and electrocardiogram findings. Differential diagnoses for myocardial infarction, systemic lupus erythematosus, and viral or bacterial causes were ruled out based on subjective and objective data. Mesalamine-induced pericarditis was considered on hospital day 2, and the drug was discontinued at discharge on day 3. Clinicians should be aware of this potential drug-related complication, as the relationship between mesalamine or sulfasalazine and pericarditis has been reported rarely in the literature.

References

Jul 18, 1992·BMJ : British Medical Journal·M T PentK C Channer
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Jan 8, 1994·BMJ : British Medical Journal·A G Lim, K R Hine
Jan 8, 1994·BMJ : British Medical Journal·T P ChuaD P Lipkin
Mar 1, 1996·Digestive Diseases and Sciences·N GujralG Levine
Nov 5, 1997·Journal of Pediatric Gastroenterology and Nutrition·G C KaiserD J Bailey
Sep 18, 1998·Journal of Pediatric Gastroenterology and Nutrition·T A Sentongo, D A Piccoli

❮ Previous
Next ❯

Citations

Jan 5, 2007·Journal of Gastroenterology and Hepatology·Gianpaolo BragagniGiorgio Zoli
Mar 6, 2010·Case Reports in Medicine·Ali RezaieGabor Gyenes
Jul 31, 2008·World Journal of Gastroenterology : WJG·Orhan AtayRobert Wyllie
Apr 19, 2007·International Journal of Colorectal Disease·Serge PerrotClaire Le Jeunne
Jan 31, 2013·Digestive Diseases and Sciences·Irene SonuMichael E Rothenberg
Nov 13, 2002·Pharmacoepidemiology and Drug Safety
Sep 12, 2009·Expert Opinion on Drug Metabolism & Toxicology·Jon Brendan Wiggins, Ramona Rajapakse
Feb 16, 2016·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Sónia BernardoLuís Araújo-Correia
Sep 3, 2013·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Carlos Galvão BragaAdelino Correia
Jan 1, 2011·Case Reports in Pediatrics·Elimarys Perez-ColonMichelle Miller
Jul 31, 2012·The American Journal of Medicine·Sumeet GandhiMichael Farkouh
Jul 3, 2015·Internal Medicine·Hidemichi KiyomatsuToshiaki Watanabe
Jun 11, 2014·Cardiology in the Young·Asha G Nair, Russell R Cross
Mar 27, 2018·BMJ Case Reports·Samuel A ShabtaieKonstantinos A Papadakis
Feb 3, 2019·BMJ Case Reports·Teresa DiasArmando Carvalho
May 23, 2018·Inflammatory Bowel Diseases·Natalie E MitchellManish Singla
Apr 13, 2019·BMJ Case Reports·Theodoros PaschalisConstantinos G Missouris
Jan 22, 2021·Clinical Journal of Gastroenterology·Benjamin Koslowsky, Amir Orlev

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.